ATTOVIA THERAPEUTICS, INC.

News Attovia Therapeutics, Inc.

Stocks

ATTO

US04987L1026

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-10-30 EDT			5-day change	1st Jan Change
15.19 ^USD	-0.52%		+9.83%	-

09-20	Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to S&P TMI Index	CI
09-16	Attovia Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 10:00 AM

All News

Mentions Relevance

10-27	Attovia Therapeutics to Participate in Upcoming Investor Conferences	GL
09-28	Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026	GL
09-20	Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to S&P TMI Index	CI
09-16	Attovia Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 10:00 AM
09-03	Attovia Therapeutics to Participate in Upcoming Investor Conferences	GL
09-02	Attovia Therapeutics Q2 Net Loss Widens	MT
09-02	Attovia Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
09-02	Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update	GL
08-31	Attovia Therapeutics Could Serve as Key Player in Immunology, Inflammation, RBC Says	MT
08-31	Morgan Stanley Initiates Coverage on Attovia Therapeutics With Overweight Rating	MT
08-31	Leerink Partners Initiates Attovia Therapeutics at Outperform With $52 Price Target	MT
08-31	RBC Initiates Attovia Therapeutics at Outperform, Speculative Risk With $45 Price Target	MT
08-31	Citigroup Initiates Attovia Therapeutics at Buy With $30 Price Target	MT
08-14	Attovia Therapeutics Insider Bought Shares Worth $10,285,000, According to a Recent SEC Filing	MT
08-05	Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to NASDAQ Composite Index	CI
08-04	Attovia Therapeutics, Inc. has completed an IPO in the amount of $289 million.	CI
07-14	Attovia Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
07-14	Attovia Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-12	Attovia Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI

Become a member to access more news

New member

No results match your criteria

All News Broker Recommendations Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stocks
ATTO Stock
News Attovia Therapeutics, Inc.

As early as today, start finding the best investment opportunities!